Nam Keun Kim Selected Research

Nam Keun Kim Research Topics

Disease

33	Neoplasms (Cancer) 11/2022 - 03/2002
18	Ischemic Stroke 01/2023 - 04/2007
18	Primary Ovarian Insufficiency 02/2021 - 06/2008
16	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 01/2011
13	Stroke (Strokes) 01/2023 - 09/2011
11	Spontaneous Abortion (Miscarriage) 09/2014 - 01/2006
7	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 04/2011
6	Coronary Artery Disease (Coronary Atherosclerosis) 08/2023 - 01/2007
6	Inflammation (Inflammations) 01/2023 - 11/2012
6	Brain Infarction 03/2021 - 01/2010
6	Stomach Neoplasms (Stomach Cancer) 11/2013 - 05/2005
5	Carcinogenesis 09/2018 - 03/2002
5	Colonic Neoplasms (Colon Cancer) 11/2014 - 07/2005
4	Thrombosis (Thrombus) 08/2019 - 10/2013
4	Venous Thromboembolism 08/2019 - 07/2012
4	Hepatocellular Carcinoma (Hepatoma) 01/2016 - 09/2008
4	Moyamoya Disease (Moya-Moya Disease) 10/2014 - 01/2012
3	Rectal Neoplasms (Rectal Cancer) 05/2019 - 12/2013
3	Diabetes Mellitus 01/2019 - 05/2010
3	Atherosclerosis 01/2019 - 09/2011
3	Hypertension (High Blood Pressure) 01/2019 - 06/2014
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 09/2007 - 05/2005
3	Male Infertility (Male Sterility) 12/2006 - 03/2002
2	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 01/2019
2	Neoplasm Metastasis (Metastasis) 01/2020 - 06/2015
2	Compression Fractures (Compression Fracture) 01/2020 - 12/2016
2	Hyperlipidemias (Hyperlipidemia) 01/2020 - 01/2019
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2018 - 05/2005
2	Ischemia 07/2016 - 07/2012
2	Breast Neoplasms (Breast Cancer) 04/2015 - 02/2005
2	Hyperhomocysteinemia 10/2014 - 01/2006
2	Cardiovascular Diseases (Cardiovascular Disease) 02/2013 - 09/2011
2	Basal Cell Carcinoma (Rodent Ulcer) 09/2010 - 05/2007
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2010 - 05/2007
2	Infertility (Sterility) 03/2003 - 03/2002
1	Hypoxia (Hypoxemia) 10/2020
1	Arterial Occlusive Diseases (Arterial Occlusive Disease) 10/2020
1	Osteoporosis 01/2020
1	Blood Coagulation Disorders 01/2020
1	Macular Degeneration (Age-Related Maculopathy) 12/2019
1	Atypical Hemolytic Uremic Syndrome 09/2019
1	Thrombotic Thrombocytopenic Purpura 09/2019

Drug/Important Bio-Agent (IBA)

27	MicroRNAs (MicroRNA)IBA 11/2020 - 11/2011
17	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 01/2017 - 07/2005
15	Folic Acid (Vitamin M)FDA LinkGeneric 01/2020 - 05/2005
12	HomocysteineIBA 01/2020 - 01/2006
12	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2018 - 07/2007
11	DNA (Deoxyribonucleic Acid)IBA 02/2013 - 03/2002
10	Thymidylate SynthaseIBA 08/2023 - 07/2005
9	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 01/2022 - 01/2007
7	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2014
7	Proteins (Proteins, Gene)FDA Link 10/2020 - 03/2002
5	Plasminogen Activators (Plasminogen Activator)IBA 01/2023 - 03/2014
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2023 - 01/2010
5	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2022 - 01/2007
5	5,10-methylenetetrahydrofolic acidIBA 09/2010 - 05/2005
5	Oxidoreductases (Dehydrogenase)IBA 09/2010 - 05/2005
4	Plasminogen Activator Inhibitor 1IBA 01/2023 - 10/2013
4	Phosphotransferases (Kinase)IBA 11/2013 - 01/2012
3	Long Noncoding RNAIBA 11/2022 - 01/2020
3	Antisense RNA (Anti-Sense RNA)IBA 11/2022 - 02/2021
3	Mannitol (Osmitrol)FDA LinkGeneric 10/2020 - 01/2018
3	Reduced Folate Carrier ProteinIBA 01/2020 - 05/2012
3	EnzymesIBA 09/2007 - 03/2002
3	Messenger RNA (mRNA)IBA 11/2003 - 03/2002
2	Genetic Markers (Genetic Marker)IBA 10/2020 - 12/2013
2	Transcobalamins (Transcobalamin II)IBA 01/2020 - 09/2014
2	Complement System Proteins (Complement)IBA 12/2019 - 09/2019
2	Matrix Metalloproteinases (MMPs)IBA 02/2019 - 10/2014
2	Tissue Inhibitor of MetalloproteinasesIBA 02/2019 - 10/2014
2	Codon (Codons)IBA 02/2014 - 02/2005
2	Fluorouracil (Carac)FDA LinkGeneric 01/2014 - 07/2005
2	Type 1 Angiotensin ReceptorIBA 05/2013 - 10/2011
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 05/2013 - 10/2011
2	AngiotensinogenIBA 05/2013 - 10/2011
2	Annexin A1IBA 11/2012 - 07/2012
2	Lamivudine (Epivir)FDA Link 09/2005 - 05/2004
2	Monoclonal AntibodiesIBA 11/2003 - 03/2002
2	DNA-3-methyladenine glycosidase IIIBA 03/2003 - 03/2002
1	Interleukin-1beta (Interleukin 1 beta)IBA 01/2023
1	oxidized low density lipoproteinIBA 01/2023
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2023
1	Interleukin-6 (Interleukin 6)IBA 01/2023
1	CytokinesIBA 01/2023
1	Neprilysin (Neutral Endopeptidase)IBA 01/2021
1	Therapeutic UsesIBA 01/2021
1	Lipoproteins (Lipoprotein)IBA 11/2020
1	ChemokinesIBA 10/2020
1	LigandsIBA 10/2020
1	Vitamin B Complex (B Vitamins)IBA 01/2020
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 01/2020
1	Vitamin D FDA LinkGeneric 01/2020
1	Immunologic Factors (Immunomodulators)IBA 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	Thiamine (Aneurin)FDA Link 01/2020
1	Complement Factor H (Factor H)IBA 12/2019
1	Complement Factor D (Factor D)IBA 12/2019

Therapy/Procedure

4	Drug Therapy (Chemotherapy) 04/2016 - 07/2005
2	Therapeutics 01/2019 - 05/2004
1	Intravenous Administration 10/2020